> top > docs > PMC:1189074 > spans > 12438-14406 > annotations

PMC:1189074 / 12438-14406 JSONTXT

Annnotations TAB JSON ListView MergeView

craft-sa-dev

Id Subject Object Predicate Lexical cue
T7957 1967-1968 . denotes .
T7956 1959-1967 NN denotes asterisk
T7955 1956-1958 DT denotes an
T7954 1953-1955 IN denotes by
T7953 1939-1942 VBP denotes are
T7952 1943-1952 VBN denotes indicated
T7951 1929-1938 NNS denotes standards
T7950 1920-1928 JJ denotes Internal
T7949 1919-1968 sentence denotes Internal standards are indicated by an asterisk.
T7948 1918-1919 . denotes .
T7947 1908-1918 NN denotes deficiency
T7946 1903-1907 NN denotes MCAD
T7945 1898-1902 IN denotes with
T7944 1884-1889 JJ denotes human
T7943 1890-1897 NN denotes patient
T7942 1882-1883 DT denotes a
T7941 1879-1881 IN denotes to
T7940 1870-1878 VBN denotes compared
T7939 1862-1863 SYM denotes −
T7938 1861-1862 HYPH denotes /
T7937 1860-1861 SYM denotes −
T7936 1856-1860 NN denotes MCAD
T7935 1864-1869 NN denotes mouse
T7934 1853-1855 DT denotes an
T7933 1850-1852 IN denotes of
T7932 1828-1841 NN denotes acylcarnitine
T7931 1823-1827 NN denotes Bile
T7930 1821-1822 -RRB- denotes )
T7929 1842-1849 NN denotes profile
T7928 1820-1821 LS denotes C
T7927 1819-1820 -LRB- denotes (
T7926 1818-1919 sentence denotes (C) Bile acylcarnitine profile of an MCAD−/− mouse compared to a human patient with MCAD deficiency.
T7925 1817-1818 . denotes .
T7924 1812-1817 CD denotes 0.001
T7923 1810-1811 SYM denotes <
T7922 1808-1809 NN denotes p
T7921 1798-1807 VBZ denotes indicates
T7920 1789-1797 NN denotes Asterisk
T7919 1788-1818 sentence denotes Asterisk indicates p < 0.001.
T7918 1787-1788 . denotes .
T7917 1785-1787 NN denotes SD
T7916 1783-1784 SYM denotes ±
T7915 1776-1782 NNS denotes values
T7914 1771-1775 NN denotes mean
T7913 1761-1766 VBN denotes shown
T7912 1767-1770 VBP denotes are
T7911 1754-1760 NNS denotes Values
T7910 1753-1788 sentence denotes Values shown are mean values ± SD.
T7909 1752-1753 . denotes .
T7908 1743-1752 VBN denotes indicated
T7907 1740-1742 IN denotes as
T7906 1738-1739 -RRB- denotes )
T7905 1737-1738 NN denotes A
T7904 1736-1737 -LRB- denotes (
T7903 1733-1735 IN denotes in
T7902 1727-1732 VBN denotes shown
T7901 1717-1721 JJ denotes same
T7900 1722-1726 NNS denotes mice
T7899 1713-1716 DT denotes the
T7898 1710-1712 IN denotes of
T7897 1695-1709 NNS denotes acylcarnitines
T7896 1690-1694 NN denotes bile
T7895 1687-1689 IN denotes in
T7894 1676-1686 NNS denotes elevations
T7893 1664-1675 JJ denotes significant
T7892 1654-1659 EX denotes There
T7891 1652-1653 -RRB- denotes )
T7890 1660-1663 VBP denotes are
T7889 1651-1652 LS denotes B
T7888 1650-1651 -LRB- denotes (
T7887 1649-1753 sentence denotes (B) There are significant elevations in bile acylcarnitines of the same mice shown in (A) as indicated.
T7886 1648-1649 . denotes .
T7885 1644-1648 CD denotes 0.01
T7884 1642-1643 SYM denotes <
T7883 1640-1641 NN denotes p
T7882 1630-1639 VBZ denotes indicates
T7881 1628-1629 SYM denotes ‡
T7880 1624-1627 CC denotes and
T7879 1618-1623 CD denotes 0.002
T7878 1616-1617 SYM denotes <
T7877 1614-1615 NN denotes p
T7876 1604-1613 VBZ denotes indicates
T7875 1595-1603 NN denotes Asterisk
T7874 1594-1649 sentence denotes Asterisk indicates p < 0.002 and ‡ indicates p < 0.01.
T7873 1593-1594 . denotes .
T7872 1592-1593 -RRB- denotes )
T7871 1590-1592 NN denotes SD
T7870 1589-1590 -LRB- denotes (
T7869 1579-1588 NN denotes deviation
T7868 1570-1578 JJ denotes standard
T7867 1568-1569 SYM denotes ±
T7866 1561-1567 NNS denotes values
T7865 1556-1560 NN denotes mean
T7864 1546-1551 VBN denotes shown
T7863 1552-1555 VBP denotes are
T7862 1539-1545 NNS denotes Values
T7861 1538-1594 sentence denotes Values shown are mean values ± standard deviation (SD).
T7860 1537-1538 . denotes .
T7859 1531-1532 SYM denotes −
T7858 1530-1531 HYPH denotes /
T7857 1529-1530 SYM denotes −
T7856 1533-1537 NNS denotes mice
T7855 1525-1529 NN denotes MCAD
T7854 1522-1524 IN denotes in
T7853 1512-1521 VBN denotes indicated
T7852 1509-1511 IN denotes as
T7851 1501-1508 NNS denotes species
T7850 1487-1500 NN denotes acylcarnitine
T7849 1484-1486 IN denotes in
T7848 1473-1483 NNS denotes elevations
T7847 1461-1472 JJ denotes significant
T7846 1457-1460 VBP denotes are
T7845 1451-1456 EX denotes There
T7844 1450-1538 sentence denotes There are significant elevations in acylcarnitine species as indicated in MCAD−/− mice.
T7843 1449-1450 -RRB- denotes )
T7842 1446-1447 SYM denotes =
T7841 1444-1445 NN denotes n
T7840 1448-1449 CD denotes 4
T7839 1443-1444 -LRB- denotes (
T7838 1436-1437 SYM denotes −
T7837 1435-1436 HYPH denotes /
T7836 1434-1435 SYM denotes −
T7835 1430-1434 NN denotes MCAD
T7834 1426-1429 CC denotes and
T7833 1424-1425 -RRB- denotes )
T7832 1421-1422 SYM denotes =
T7831 1419-1420 NN denotes n
T7830 1423-1424 CD denotes 4
T7829 1418-1419 -LRB- denotes (
T7828 1416-1417 SYM denotes +
T7827 1415-1416 HYPH denotes /
T7826 1414-1415 SYM denotes +
T7825 1438-1442 NNS denotes mice
T7824 1410-1414 NN denotes MCAD
T7823 1407-1409 IN denotes of
T7822 1384-1397 NN denotes acylcarnitine
T7821 1378-1383 NN denotes Serum
T7820 1376-1377 -RRB- denotes )
T7819 1398-1406 NN denotes analysis
T7818 1375-1376 LS denotes A
T7817 1374-1375 -LRB- denotes (
T7816 1373-1450 sentence denotes (A) Serum acylcarnitine analysis of MCAD+/+ (n = 4) and MCAD−/− mice (n = 4)
T7815 1365-1373 NNS denotes Analyses
T7814 1351-1364 NN denotes Acylcarnitine
T3078 836-853 NN denotes decenoylcarnitine
T3077 830-835 NN denotes serum
T3076 827-829 IN denotes of
T3075 854-861 JJ denotes evident
T3074 811-812 HYPH denotes -
T3073 812-816 JJ denotes fold
T3072 807-809 IN denotes to
T3071 805-806 HYPH denotes -
T3070 810-811 CD denotes 6
T3069 804-805 CD denotes 5
T3068 817-826 NN denotes elevation
T3067 802-803 DT denotes a
T3066 798-801 VBD denotes had
T3065 791-792 SYM denotes −
T3064 790-791 HYPH denotes /
T3063 789-790 SYM denotes −
T3062 793-797 NNS denotes mice
T3061 785-789 NN denotes MCAD
T3060 781-784 CC denotes but
T3059 779-781 , denotes ,
T3058 773-774 SYM denotes −
T3057 772-773 HYPH denotes /
T3056 771-772 SYM denotes −
T3055 767-771 NN denotes MCAD
T3054 763-766 CC denotes and
T3053 761-762 SYM denotes +
T3052 760-761 HYPH denotes /
T3051 759-760 SYM denotes +
T3050 775-779 NNS denotes mice
T3049 755-759 NN denotes MCAD
T3048 747-754 IN denotes between
T3047 722-731 NN denotes carnitine
T3046 716-721 NN denotes serum
T3045 732-746 NNS denotes concentrations
T3044 710-715 JJ denotes total
T3043 707-709 IN denotes in
T3042 683-694 JJ denotes significant
T3041 695-706 NNS denotes differences
T3040 680-682 DT denotes no
T3039 664-665 SYM denotes −
T3038 663-664 HYPH denotes /
T3037 662-663 SYM denotes −
T3036 658-662 NN denotes MCAD
T3035 654-657 CC denotes and
T3034 652-653 SYM denotes +
T3033 651-652 HYPH denotes /
T3032 650-651 SYM denotes +
T3031 666-670 NNS denotes mice
T3030 646-650 NN denotes MCAD
T3029 643-645 IN denotes of
T3028 671-679 VBD denotes revealed
T3027 632-642 NN denotes Comparison
T3026 631-903 sentence denotes Comparison of MCAD+/+ and MCAD−/− mice revealed no significant differences in total serum carnitine concentrations between MCAD+/+ and MCAD−/− mice, but MCAD−/− mice had a 5- to 6-fold elevation of serum decenoylcarnitine evident in the acylcarnitine profile (Figure 4A).
T3025 630-631 . denotes .
T3024 629-630 -RRB- denotes )
T3023 620-623 RB denotes not
T3022 615-619 NNS denotes data
T3021 624-629 VBN denotes shown
T3020 614-615 -LRB- denotes (
T3019 604-613 NNS denotes genotypes
T3018 599-603 NN denotes MCAD
T3017 591-598 IN denotes between
T3016 567-578 JJ denotes significant
T3015 579-590 NNS denotes differences
T3014 564-566 DT denotes no
T3013 558-563 VBD denotes found
T3012 554-557 CC denotes and
T3011 527-538 JJ denotes acetoacetic
T3010 523-526 CC denotes and
T3009 539-553 NNS denotes concentrations
T3008 507-508 HYPH denotes -
T3007 508-522 JJ denotes hydroxybutyric
T3006 506-507 NN denotes β
T3005 491-495 RB denotes also
T3004 496-505 VBD denotes evaluated
T3003 488-490 PRP denotes We
T3002 487-631 sentence denotes We also evaluated β-hydroxybutyric and acetoacetic concentrations and found no significant differences between MCAD genotypes (data not shown).
T3001 486-487 . denotes .
T3000 476-486 NN denotes deficiency
T2999 471-475 NN denotes MCAD
T2998 468-470 IN denotes to
T2997 459-467 JJ denotes specific
T2996 455-458 RB denotes not
T2995 452-454 VBZ denotes is
T2994 447-451 NN denotes acid
T2993 440-446 JJ denotes Adipic
T2992 439-487 sentence denotes Adipic acid is not specific to MCAD deficiency.
T2991 438-439 . denotes .
T2990 437-438 -RRB- denotes )
T2989 436-437 CD denotes 1
T2988 430-435 NN denotes Table
T2987 429-430 -LRB- denotes (
T2986 415-422 JJ denotes organic
T2985 410-414 JJ denotes same
T2984 423-428 NNS denotes acids
T2983 406-409 DT denotes the
T2982 403-405 IN denotes of
T2981 384-394 JJ denotes detectable
T2980 395-402 NNS denotes amounts
T2979 381-383 DT denotes no
T2978 378-380 IN denotes to
T2977 372-377 NN denotes trace
T2976 365-371 VBD denotes showed
T2975 359-364 WDT denotes which
T2974 357-359 , denotes ,
T2973 347-348 SYM denotes +
T2972 346-347 HYPH denotes /
T2971 345-346 SYM denotes +
T2970 349-357 NNS denotes controls
T2969 341-345 NN denotes MCAD
T2968 338-340 IN denotes to
T2967 329-337 VBN denotes compared
T2966 326-328 IN denotes as
T2965 310-325 NN denotes hexanoylglycine
T2964 306-309 CC denotes and
T2963 292-299 JJ denotes sebacic
T2962 288-291 CC denotes and
T2961 286-288 , denotes ,
T2960 279-286 JJ denotes suberic
T2959 277-279 , denotes ,
T2958 300-305 NNS denotes acids
T2957 271-277 JJ denotes adipic
T2956 268-270 IN denotes of
T2955 253-267 NNS denotes concentrations
T2954 244-252 VBN denotes elevated
T2953 230-243 RB denotes significantly
T2952 213-214 SYM denotes −
T2951 212-213 HYPH denotes /
T2950 211-212 SYM denotes −
T2949 215-219 NNS denotes mice
T2948 207-211 NN denotes MCAD
T2947 205-207 , denotes ,
T2946 204-205 NN denotes h
T2945 201-203 CD denotes 18
T2944 197-200 IN denotes for
T2943 190-196 VBN denotes fasted
T2942 185-189 WRB denotes when
T2941 183-185 , denotes ,
T2940 220-229 VBD denotes developed
T2939 171-183 RB denotes Specifically
T2938 170-439 sentence denotes Specifically, when fasted for 18 h, MCAD−/− mice developed significantly elevated concentrations of adipic, suberic, and sebacic acids and hexanoylglycine as compared to MCAD+/+ controls, which showed trace to no detectable amounts of the same organic acids (Table 1).
T2937 169-170 . denotes .
T2936 155-160 JJ denotes human
T2935 161-169 NNS denotes patients
T2934 144-145 HYPH denotes -
T2933 145-154 JJ denotes deficient
T2932 140-144 NN denotes MCAD
T2931 137-139 IN denotes to
T2930 129-136 JJ denotes similar
T2929 116-120 NN denotes acid
T2928 108-115 JJ denotes organic
T2927 121-128 NN denotes profile
T2926 105-107 DT denotes an
T2925 88-89 SYM denotes −
T2924 87-88 HYPH denotes /
T2923 86-87 SYM denotes −
T2922 90-94 NNS denotes mice
T2921 82-86 NN denotes MCAD
T2920 95-104 VBD denotes developed
T2919 77-81 IN denotes that
T2918 68-76 VBD denotes revealed
T2917 59-67 NN denotes analysis
T2916 46-53 JJ denotes organic
T2915 54-58 NN denotes acid
T2914 40-45 NN denotes Urine
T2913 39-170 sentence denotes Urine organic acid analysis revealed that MCAD−/− mice developed an organic acid profile similar to MCAD-deficient human patients.
T2912 31-39 NN denotes Analysis
T2911 17-30 NN denotes Acylcarnitine
T2910 13-16 CC denotes and
T2909 8-12 NN denotes Acid
T2908 0-7 JJ denotes Organic
T3178 1339-1340 . denotes .
T3177 1324-1325 CD denotes 1
T3176 1323-1324 : denotes :
T3175 1326-1339 NN denotes acylcarnitine
T3174 1320-1323 NN denotes C10
T3173 1313-1315 PRP denotes it
T3172 1307-1312 NN denotes mouse
T3171 1303-1306 DT denotes the
T3170 1300-1302 IN denotes in
T3169 1316-1319 VBD denotes was
T3168 1292-1299 IN denotes whereas
T3167 1290-1292 , denotes ,
T3166 1284-1290 NNS denotes humans
T3165 1281-1283 IN denotes in
T3164 1267-1280 NN denotes acylcarnitine
T3163 1264-1266 NN denotes C8
T3162 1243-1254 JJ denotes predominant
T3161 1255-1259 NN denotes peak
T3160 1239-1242 DT denotes the
T3159 1237-1239 , denotes ,
T3158 1230-1237 RB denotes however
T3157 1228-1229 : denotes ;
T3156 1217-1223 NN denotes mutant
T3155 1224-1228 NNS denotes mice
T3154 1213-1216 DT denotes the
T3153 1209-1212 VBD denotes did
T3152 1206-1208 IN denotes as
T3151 1204-1206 , denotes ,
T3150 1190-1204 NNS denotes acylcarnitines
T3149 1188-1189 CD denotes 1
T3148 1187-1188 : denotes :
T3147 1184-1187 NN denotes C10
T3146 1180-1183 CC denotes and
T3145 1178-1180 , denotes ,
T3144 1176-1178 NN denotes C8
T3143 1174-1176 , denotes ,
T3142 1172-1174 NN denotes C6
T3141 1169-1171 IN denotes of
T3140 1162-1168 NNS denotes levels
T3139 1153-1161 VBN denotes elevated
T3138 1148-1152 IN denotes with
T3137 1260-1263 VBD denotes was
T3136 1140-1147 VBP denotes present
T3135 1131-1139 NNS denotes patients
T3134 1125-1130 JJ denotes Human
T3133 1124-1340 sentence denotes Human patients present with elevated levels of C6, C8, and C10:1 acylcarnitines, as did the mutant mice; however, the predominant peak was C8 acylcarnitine in humans, whereas in the mouse it was C10:1 acylcarnitine.
T3132 1123-1124 . denotes .
T3131 1122-1123 -RRB- denotes )
T3130 1120-1122 CD denotes 4C
T3129 1113-1119 NN denotes Figure
T3128 1112-1113 -LRB- denotes (
T3127 1092-1093 HYPH denotes -
T3126 1093-1102 JJ denotes deficient
T3125 1088-1092 NN denotes MCAD
T3124 1103-1111 NNS denotes patients
T3123 1082-1087 JJ denotes human
T3122 1079-1081 IN denotes of
T3121 1073-1078 DT denotes those
T3120 1068-1072 IN denotes from
T3119 1058-1067 JJ denotes different
T3118 1047-1048 SYM denotes −
T3117 1046-1047 HYPH denotes /
T3116 1045-1046 SYM denotes −
T3115 1041-1045 NN denotes MCAD
T3114 1049-1053 NNS denotes mice
T3113 1037-1040 DT denotes the
T3112 1034-1036 IN denotes of
T3111 1011-1024 NN denotes acylcarnitine
T3110 1025-1033 NNS denotes profiles
T3109 1007-1010 DT denotes the
T3108 1005-1007 , denotes ,
T3107 1054-1057 VBP denotes are
T3106 998-1005 RB denotes However
T3105 997-1124 sentence denotes However, the acylcarnitine profiles of the MCAD−/− mice are different from those of human MCAD-deficient patients (Figure 4C).
T3104 996-997 . denotes .
T3103 995-996 -RRB- denotes )
T3102 993-995 CD denotes 4B
T3101 986-992 NN denotes Figure
T3100 985-986 -LRB- denotes (
T3099 979-984 NN denotes serum
T3098 976-978 IN denotes in
T3097 973-975 IN denotes as
T3096 951-964 NN denotes acylcarnitine
T3095 943-950 JJ denotes similar
T3094 965-972 NN denotes pattern
T3093 941-942 DT denotes a
T3092 932-940 VBD denotes revealed
T3091 923-931 NN denotes analysis
T3090 909-922 NN denotes acylcarnitine
T3089 904-908 NN denotes Bile
T3088 903-997 sentence denotes Bile acylcarnitine analysis revealed a similar acylcarnitine pattern as in serum (Figure 4B).
T3087 902-903 . denotes .
T3086 901-902 -RRB- denotes )
T3085 899-901 CD denotes 4A
T3084 892-898 NN denotes Figure
T3083 891-892 -LRB- denotes (
T3082 869-882 NN denotes acylcarnitine
T3081 883-890 NN denotes profile
T3080 865-868 DT denotes the
T3079 862-864 IN denotes in
R1812 T2908 T2909 amod Organic,Acid
R1813 T2910 T2909 cc and,Acid
R1814 T2911 T2912 compound Acylcarnitine,Analysis
R1815 T2912 T2909 conj Analysis,Acid
R1816 T2914 T2915 nmod Urine,acid
R1817 T2915 T2917 compound acid,analysis
R1818 T2916 T2915 amod organic,acid
R1819 T2917 T2918 nsubj analysis,revealed
R1820 T2919 T2920 mark that,developed
R1821 T2920 T2918 ccomp developed,revealed
R1822 T2921 T2922 nmod MCAD,mice
R1823 T2922 T2920 nsubj mice,developed
R1824 T2923 T2921 punct −,MCAD
R1825 T2924 T2921 punct /,MCAD
R1826 T2925 T2921 punct −,MCAD
R1827 T2926 T2927 det an,profile
R1828 T2927 T2920 dobj profile,developed
R1829 T2928 T2929 amod organic,acid
R1830 T2929 T2927 compound acid,profile
R1831 T2930 T2927 amod similar,profile
R1832 T2931 T2930 prep to,similar
R1833 T2932 T2933 npadvmod MCAD,deficient
R1834 T2933 T2935 amod deficient,patients
R1835 T2934 T2933 punct -,deficient
R1836 T2935 T2931 pobj patients,to
R1837 T2936 T2935 amod human,patients
R1838 T2937 T2918 punct .,revealed
R1839 T2939 T2940 advmod Specifically,developed
R1840 T2941 T2940 punct ", ",developed
R1841 T2942 T2943 advmod when,fasted
R1842 T2943 T2940 advcl fasted,developed
R1843 T2944 T2943 prep for,fasted
R1844 T2945 T2946 nummod 18,h
R1845 T2946 T2944 pobj h,for
R1846 T2947 T2940 punct ", ",developed
R1847 T2948 T2949 nmod MCAD,mice
R1848 T2949 T2940 nsubj mice,developed
R1849 T2950 T2948 punct −,MCAD
R1850 T2951 T2948 punct /,MCAD
R1851 T2952 T2948 punct −,MCAD
R1852 T2953 T2954 advmod significantly,elevated
R1853 T2954 T2955 amod elevated,concentrations
R1854 T2955 T2940 dobj concentrations,developed
R1855 T2956 T2955 prep of,concentrations
R1856 T2957 T2958 amod adipic,acids
R1857 T2958 T2956 pobj acids,of
R1858 T2959 T2957 punct ", ",adipic
R1859 T2960 T2957 conj suberic,adipic
R1860 T2961 T2960 punct ", ",suberic
R1861 T2962 T2960 cc and,suberic
R1862 T2963 T2960 conj sebacic,suberic
R1863 T2964 T2958 cc and,acids
R1864 T2965 T2958 conj hexanoylglycine,acids
R1865 T2966 T2967 mark as,compared
R1866 T2967 T2940 advcl compared,developed
R1867 T2968 T2967 prep to,compared
R1868 T2969 T2970 nmod MCAD,controls
R1869 T2970 T2968 pobj controls,to
R1870 T2971 T2969 punct +,MCAD
R1871 T2972 T2969 punct /,MCAD
R1872 T2973 T2969 punct +,MCAD
R1873 T2974 T2970 punct ", ",controls
R1874 T2975 T2976 dep which,showed
R1875 T2976 T2970 relcl showed,controls
R1876 T2977 T2976 dobj trace,showed
R1877 T2978 T2977 prep to,trace
R1878 T2979 T2980 det no,amounts
R1879 T2980 T2978 pobj amounts,to
R1880 T2981 T2980 amod detectable,amounts
R1881 T2982 T2977 prep of,trace
R1882 T2983 T2984 det the,acids
R1883 T2984 T2982 pobj acids,of
R1884 T2985 T2984 amod same,acids
R1885 T2986 T2984 amod organic,acids
R1886 T2987 T2988 punct (,Table
R1887 T2988 T2940 parataxis Table,developed
R1888 T2989 T2988 nummod 1,Table
R1889 T2990 T2988 punct ),Table
R1890 T2991 T2940 punct .,developed
R1891 T2993 T2994 amod Adipic,acid
R1892 T2994 T2995 nsubj acid,is
R1893 T2996 T2995 neg not,is
R1894 T2997 T2995 acomp specific,is
R1895 T2998 T2997 prep to,specific
R1896 T2999 T3000 compound MCAD,deficiency
R1897 T3000 T2998 pobj deficiency,to
R1898 T3001 T2995 punct .,is
R1899 T3003 T3004 nsubj We,evaluated
R1900 T3005 T3004 advmod also,evaluated
R1901 T3006 T3007 npadvmod β,hydroxybutyric
R1902 T3007 T3009 amod hydroxybutyric,concentrations
R1903 T3008 T3007 punct -,hydroxybutyric
R1904 T3009 T3004 dobj concentrations,evaluated
R1905 T3010 T3007 cc and,hydroxybutyric
R1906 T3011 T3007 conj acetoacetic,hydroxybutyric
R1907 T3012 T3004 cc and,evaluated
R1908 T3013 T3004 conj found,evaluated
R1909 T3014 T3015 det no,differences
R1910 T3015 T3013 dobj differences,found
R1911 T3016 T3015 amod significant,differences
R1912 T3017 T3015 prep between,differences
R1913 T3018 T3019 compound MCAD,genotypes
R1914 T3019 T3017 pobj genotypes,between
R1915 T3020 T3021 punct (,shown
R1916 T3021 T3013 parataxis shown,found
R1917 T3022 T3021 nsubj data,shown
R1918 T3023 T3021 neg not,shown
R1919 T3024 T3021 punct ),shown
R1920 T3025 T3004 punct .,evaluated
R1921 T3027 T3028 nsubj Comparison,revealed
R1922 T3029 T3027 prep of,Comparison
R1923 T3030 T3031 nmod MCAD,mice
R1924 T3031 T3029 pobj mice,of
R1925 T3032 T3030 punct +,MCAD
R1926 T3033 T3030 punct /,MCAD
R1927 T3034 T3030 punct +,MCAD
R1928 T3035 T3030 cc and,MCAD
R1929 T3036 T3030 conj MCAD,MCAD
R1930 T3037 T3036 punct −,MCAD
R1931 T3038 T3036 punct /,MCAD
R1932 T3039 T3036 punct −,MCAD
R1933 T3040 T3041 det no,differences
R1934 T3041 T3028 dobj differences,revealed
R1935 T3042 T3041 amod significant,differences
R1936 T3043 T3041 prep in,differences
R1937 T3044 T3045 amod total,concentrations
R1938 T3045 T3043 pobj concentrations,in
R1939 T3046 T3045 compound serum,concentrations
R1940 T3047 T3045 compound carnitine,concentrations
R1941 T3048 T3041 prep between,differences
R1942 T3049 T3050 nmod MCAD,mice
R1943 T3050 T3048 pobj mice,between
R1944 T3051 T3049 punct +,MCAD
R1945 T3052 T3049 punct /,MCAD
R1946 T3053 T3049 punct +,MCAD
R1947 T3054 T3049 cc and,MCAD
R1948 T3055 T3049 conj MCAD,MCAD
R1949 T3056 T3055 punct −,MCAD
R1950 T3057 T3055 punct /,MCAD
R1951 T3058 T3055 punct −,MCAD
R1952 T3059 T3028 punct ", ",revealed
R1953 T3060 T3028 cc but,revealed
R1954 T3061 T3062 nmod MCAD,mice
R1955 T3062 T3066 nsubj mice,had
R1956 T3063 T3061 punct −,MCAD
R1957 T3064 T3061 punct /,MCAD
R1958 T3065 T3061 punct −,MCAD
R1959 T3066 T3028 conj had,revealed
R1960 T3067 T3068 det a,elevation
R1961 T3068 T3075 nsubj elevation,evident
R1962 T3069 T3070 quantmod 5,6
R1963 T3070 T3073 quantmod 6,fold
R1964 T3071 T3070 punct -,6
R1965 T3072 T3070 quantmod to,6
R1966 T3073 T3068 nummod fold,elevation
R1967 T3074 T3073 punct -,fold
R1968 T3075 T3066 ccomp evident,had
R1969 T3076 T3068 prep of,elevation
R1970 T3077 T3078 compound serum,decenoylcarnitine
R1971 T3078 T3076 pobj decenoylcarnitine,of
R1972 T3079 T3075 prep in,evident
R1973 T3080 T3081 det the,profile
R1974 T3081 T3079 pobj profile,in
R1975 T3082 T3081 compound acylcarnitine,profile
R1976 T3083 T3084 punct (,Figure
R1977 T3084 T3066 parataxis Figure,had
R1978 T3085 T3084 nummod 4A,Figure
R1979 T3086 T3084 punct ),Figure
R1980 T3087 T3066 punct .,had
R1981 T3089 T3090 compound Bile,acylcarnitine
R1982 T3090 T3091 compound acylcarnitine,analysis
R1983 T3091 T3092 nsubj analysis,revealed
R1984 T3093 T3094 det a,pattern
R1985 T3094 T3092 dobj pattern,revealed
R1986 T3095 T3094 amod similar,pattern
R1987 T3096 T3094 compound acylcarnitine,pattern
R1988 T3097 T3094 prep as,pattern
R1989 T3098 T3097 prep in,as
R1990 T3099 T3098 pobj serum,in
R1991 T3100 T3101 punct (,Figure
R1992 T3101 T3092 parataxis Figure,revealed
R1993 T3102 T3101 nummod 4B,Figure
R1994 T3103 T3101 punct ),Figure
R1995 T3104 T3092 punct .,revealed
R1996 T3106 T3107 advmod However,are
R1997 T3108 T3107 punct ", ",are
R1998 T3109 T3110 det the,profiles
R1999 T3110 T3107 nsubj profiles,are
R2000 T3111 T3110 compound acylcarnitine,profiles
R2001 T3112 T3110 prep of,profiles
R2002 T3113 T3114 det the,mice
R2003 T3114 T3112 pobj mice,of
R2004 T3115 T3114 nmod MCAD,mice
R2005 T3116 T3115 punct −,MCAD
R2006 T3117 T3115 punct /,MCAD
R2007 T3118 T3115 punct −,MCAD
R2008 T3119 T3107 acomp different,are
R2009 T3120 T3119 prep from,different
R2010 T3121 T3120 pobj those,from
R2011 T3122 T3121 prep of,those
R2012 T3123 T3124 amod human,patients
R2013 T3124 T3122 pobj patients,of
R2014 T3125 T3126 npadvmod MCAD,deficient
R2015 T3126 T3124 amod deficient,patients
R2016 T3127 T3126 punct -,deficient
R2017 T3128 T3129 punct (,Figure
R2018 T3129 T3107 parataxis Figure,are
R2019 T3130 T3129 nummod 4C,Figure
R2020 T3131 T3129 punct ),Figure
R2021 T3132 T3107 punct .,are
R2022 T3134 T3135 amod Human,patients
R2023 T3135 T3136 nsubj patients,present
R2024 T3136 T3137 ccomp present,was
R2025 T3138 T3136 prep with,present
R2026 T3139 T3140 amod elevated,levels
R2027 T3140 T3138 pobj levels,with
R2028 T3141 T3140 prep of,levels
R2029 T3142 T3141 pobj C6,of
R2030 T3143 T3142 punct ", ",C6
R2031 T3144 T3142 conj C8,C6
R2032 T3145 T3144 punct ", ",C8
R2033 T3146 T3144 cc and,C8
R2034 T3147 T3144 conj C10,C8
R2035 T3148 T3147 punct :,C10
R2036 T3149 T3147 nummod 1,C10
R2037 T3150 T3142 appos acylcarnitines,C6
R2038 T3151 T3136 punct ", ",present
R2039 T3152 T3153 mark as,did
R2040 T3153 T3136 advcl did,present
R2041 T3154 T3155 det the,mice
R2042 T3155 T3153 nsubj mice,did
R2043 T3156 T3155 compound mutant,mice
R2044 T3157 T3137 punct ;,was
R2045 T3158 T3137 advmod however,was
R2046 T3159 T3137 punct ", ",was
R2047 T3160 T3161 det the,peak
R2048 T3161 T3137 nsubj peak,was
R2049 T3162 T3161 amod predominant,peak
R2050 T3163 T3164 compound C8,acylcarnitine
R2051 T3164 T3137 attr acylcarnitine,was
R2052 T3165 T3137 prep in,was
R2053 T3166 T3165 pobj humans,in
R2054 T3167 T3137 punct ", ",was
R2055 T3168 T3169 mark whereas,was
R2056 T3169 T3137 advcl was,was
R2057 T3170 T3169 prep in,was
R2058 T3171 T3172 det the,mouse
R2059 T3172 T3170 pobj mouse,in
R2060 T3173 T3169 nsubj it,was
R2061 T3174 T3175 nmod C10,acylcarnitine
R2062 T3175 T3169 attr acylcarnitine,was
R2063 T3176 T3174 punct :,C10
R2064 T3177 T3174 nummod 1,C10
R2065 T3178 T3137 punct .,was
R5004 T7814 T7815 compound Acylcarnitine,Analyses
R5005 T7817 T7818 punct (,A
R5006 T7818 T7819 meta A,analysis
R5007 T7820 T7818 punct ),A
R5008 T7821 T7822 compound Serum,acylcarnitine
R5009 T7822 T7819 compound acylcarnitine,analysis
R5010 T7823 T7819 prep of,analysis
R5011 T7824 T7825 nmod MCAD,mice
R5012 T7825 T7823 pobj mice,of
R5013 T7826 T7824 punct +,MCAD
R5014 T7827 T7824 punct /,MCAD
R5015 T7828 T7824 punct +,MCAD
R5016 T7829 T7830 punct (,4
R5017 T7830 T7824 parataxis 4,MCAD
R5018 T7831 T7830 nsubj n,4
R5019 T7832 T7830 punct =,4
R5020 T7833 T7830 punct ),4
R5021 T7834 T7824 cc and,MCAD
R5022 T7835 T7824 conj MCAD,MCAD
R5023 T7836 T7835 punct −,MCAD
R5024 T7837 T7835 punct /,MCAD
R5025 T7838 T7835 punct −,MCAD
R5026 T7839 T7840 punct (,4
R5027 T7840 T7825 parataxis 4,mice
R5028 T7841 T7840 nsubj n,4
R5029 T7842 T7840 punct =,4
R5030 T7843 T7840 punct ),4
R5031 T7845 T7846 expl There,are
R5032 T7847 T7848 amod significant,elevations
R5033 T7848 T7846 attr elevations,are
R5034 T7849 T7846 prep in,are
R5035 T7850 T7851 compound acylcarnitine,species
R5036 T7851 T7849 pobj species,in
R5037 T7852 T7853 mark as,indicated
R5038 T7853 T7846 advcl indicated,are
R5039 T7854 T7853 prep in,indicated
R5040 T7855 T7856 nmod MCAD,mice
R5041 T7856 T7854 pobj mice,in
R5042 T7857 T7855 punct −,MCAD
R5043 T7858 T7855 punct /,MCAD
R5044 T7859 T7855 punct −,MCAD
R5045 T7860 T7846 punct .,are
R5046 T7862 T7863 nsubj Values,are
R5047 T7864 T7862 acl shown,Values
R5048 T7865 T7866 compound mean,values
R5049 T7866 T7863 attr values,are
R5050 T7867 T7866 punct ±,values
R5051 T7868 T7869 amod standard,deviation
R5052 T7869 T7866 appos deviation,values
R5053 T7870 T7869 punct (,deviation
R5054 T7871 T7869 appos SD,deviation
R5055 T7872 T7863 punct ),are
R5056 T7873 T7863 punct .,are
R5057 T7875 T7876 nsubj Asterisk,indicates
R5058 T7877 T7876 dobj p,indicates
R5059 T7878 T7879 punct <,0.002
R5060 T7879 T7877 amod 0.002,p
R5061 T7880 T7876 cc and,indicates
R5062 T7881 T7882 nsubj ‡,indicates
R5063 T7882 T7876 conj indicates,indicates
R5064 T7883 T7882 dobj p,indicates
R5065 T7884 T7885 punct <,0.01
R5066 T7885 T7883 amod 0.01,p
R5067 T7886 T7882 punct .,indicates
R5068 T7888 T7889 punct (,B
R5069 T7889 T7890 meta B,are
R5070 T7891 T7889 punct ),B
R5071 T7892 T7890 expl There,are
R5072 T7893 T7894 amod significant,elevations
R5073 T7894 T7890 attr elevations,are
R5074 T7895 T7894 prep in,elevations
R5075 T7896 T7897 compound bile,acylcarnitines
R5076 T7897 T7895 pobj acylcarnitines,in
R5077 T7898 T7897 prep of,acylcarnitines
R5078 T7899 T7900 det the,mice
R5079 T7900 T7898 pobj mice,of
R5080 T7901 T7900 amod same,mice
R5081 T7902 T7900 acl shown,mice
R5082 T7903 T7902 prep in,shown
R5083 T7904 T7903 punct (,in
R5084 T7905 T7903 pobj A,in
R5085 T7906 T7902 punct ),shown
R5086 T7907 T7908 mark as,indicated
R5087 T7908 T7902 advcl indicated,shown
R5088 T7909 T7890 punct .,are
R5089 T7911 T7912 nsubj Values,are
R5090 T7913 T7911 acl shown,Values
R5091 T7914 T7915 compound mean,values
R5092 T7915 T7912 attr values,are
R5093 T7916 T7915 punct ±,values
R5094 T7917 T7915 appos SD,values
R5095 T7918 T7912 punct .,are
R5096 T7920 T7921 nsubj Asterisk,indicates
R5097 T7922 T7921 dobj p,indicates
R5098 T7923 T7924 punct <,0.001
R5099 T7924 T7922 amod 0.001,p
R5100 T7925 T7921 punct .,indicates
R5101 T7927 T7928 punct (,C
R5102 T7928 T7929 meta C,profile
R5103 T7930 T7928 punct ),C
R5104 T7931 T7932 compound Bile,acylcarnitine
R5105 T7932 T7929 compound acylcarnitine,profile
R5106 T7933 T7929 prep of,profile
R5107 T7934 T7935 det an,mouse
R5108 T7935 T7933 pobj mouse,of
R5109 T7936 T7935 nmod MCAD,mouse
R5110 T7937 T7936 punct −,MCAD
R5111 T7938 T7936 punct /,MCAD
R5112 T7939 T7936 punct −,MCAD
R5113 T7940 T7929 prep compared,profile
R5114 T7941 T7940 prep to,compared
R5115 T7942 T7943 det a,patient
R5116 T7943 T7941 pobj patient,to
R5117 T7944 T7943 amod human,patient
R5118 T7945 T7943 prep with,patient
R5119 T7946 T7947 compound MCAD,deficiency
R5120 T7947 T7945 pobj deficiency,with
R5121 T7948 T7929 punct .,profile
R5122 T7950 T7951 amod Internal,standards
R5123 T7951 T7952 nsubjpass standards,indicated
R5124 T7953 T7952 auxpass are,indicated
R5125 T7954 T7952 prep by,indicated
R5126 T7955 T7956 det an,asterisk
R5127 T7956 T7954 pobj asterisk,by
R5128 T7957 T7952 punct .,indicated

craft-ca-core-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T7970 1884-1889 NCBITaxon:9606 denotes human
T7969 1864-1869 NCBITaxon:10088 denotes mouse
T7968 1828-1841 CHEBI:17387 denotes acylcarnitine
T7967 1823-1827 UBERON:0001970 denotes Bile
T7966 1722-1726 NCBITaxon:10088 denotes mice
T7965 1695-1709 CHEBI:17387 denotes acylcarnitines
T7964 1690-1694 UBERON:0001970 denotes bile
T7963 1533-1537 NCBITaxon:10088 denotes mice
T7962 1487-1500 CHEBI:17387 denotes acylcarnitine
T7961 1438-1442 NCBITaxon:10088 denotes mice
T7960 1384-1397 CHEBI:17387 denotes acylcarnitine
T7959 1378-1383 UBERON:0001977 denotes Serum
T7958 1351-1364 CHEBI:17387 denotes Acylcarnitine
T3218 1326-1339 CHEBI:17387 denotes acylcarnitine
T3217 1307-1312 NCBITaxon:10088 denotes mouse
T3216 1284-1290 NCBITaxon:9606 denotes humans
T3215 1267-1280 CHEBI:17387 denotes acylcarnitine
T3214 1224-1228 NCBITaxon:10088 denotes mice
T3213 1190-1204 CHEBI:17387 denotes acylcarnitines
T3212 1125-1130 NCBITaxon:9606 denotes Human
T3211 1082-1087 NCBITaxon:9606 denotes human
T3210 1049-1053 NCBITaxon:10088 denotes mice
T3209 1011-1024 CHEBI:17387 denotes acylcarnitine
T3208 979-984 UBERON:0001977 denotes serum
T3207 951-964 CHEBI:17387 denotes acylcarnitine
T3206 909-922 CHEBI:17387 denotes acylcarnitine
T3205 904-908 UBERON:0001970 denotes Bile
T3204 869-882 CHEBI:17387 denotes acylcarnitine
T3203 836-853 CHEBI:86063 denotes decenoylcarnitine
T3202 830-835 UBERON:0001977 denotes serum
T3201 793-797 NCBITaxon:10088 denotes mice
T3200 775-779 NCBITaxon:10088 denotes mice
T3199 722-731 CHEBI:17126 denotes carnitine
T3198 716-721 UBERON:0001977 denotes serum
T3197 666-670 NCBITaxon:10088 denotes mice
T3196 527-538 CHEBI:15344 denotes acetoacetic
T3195 506-522 CHEBI:20067 denotes β-hydroxybutyric
T3194 440-451 CHEBI:30832 denotes Adipic acid
T3193 415-428 CHEBI:64709 denotes organic acids
T3192 310-325 CHEBI:64390 denotes hexanoylglycine
T3191 292-305 CHEBI:41865 denotes sebacic acids
T3190 300-305 CHEBI:9300 denotes acids
T3189 279-286 _FRAGMENT denotes suberic
T3188 300-305 CHEBI:30832 denotes acids
T3187 271-277 _FRAGMENT denotes adipic
T3186 215-219 NCBITaxon:10088 denotes mice
T3185 155-160 NCBITaxon:9606 denotes human
T3184 108-120 CHEBI:64709 denotes organic acid
T3183 90-94 NCBITaxon:10088 denotes mice
T3182 46-58 CHEBI:64709 denotes organic acid
T3181 40-45 UBERON:0001088 denotes Urine
T3180 17-30 CHEBI:17387 denotes Acylcarnitine
T3179 0-12 CHEBI:64709 denotes Organic Acid
R2066 T3188 T3187 _lexicallyChainedTo acids,adipic
R2067 T3190 T3189 _lexicallyChainedTo acids,suberic

craft-ca-core-ex-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T7996 1903-1907 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T7995 1884-1889 NCBITaxon:9606 denotes human
T7994 1864-1869 NCBITaxon:10088 denotes mouse
T7993 1862-1863 SO_EXT:sequence_nullness_or_absence denotes −
T7992 1860-1861 SO_EXT:sequence_nullness_or_absence denotes −
T7991 1856-1860 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T7990 1828-1841 CHEBI:17387 denotes acylcarnitine
T7989 1823-1827 UBERON:0001970 denotes Bile
T7988 1722-1726 NCBITaxon:10088 denotes mice
T7987 1695-1709 CHEBI:17387 denotes acylcarnitines
T7986 1690-1694 UBERON:0001970 denotes bile
T7985 1533-1537 NCBITaxon:10088 denotes mice
T7984 1531-1532 SO_EXT:sequence_nullness_or_absence denotes −
T7983 1529-1530 SO_EXT:sequence_nullness_or_absence denotes −
T7982 1525-1529 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T7981 1487-1500 CHEBI:17387 denotes acylcarnitine
T7980 1438-1442 NCBITaxon:10088 denotes mice
T7979 1436-1437 SO_EXT:sequence_nullness_or_absence denotes −
T7978 1434-1435 SO_EXT:sequence_nullness_or_absence denotes −
T7977 1430-1434 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T7976 1416-1417 SO_EXT:normal_or_wild_type_or_present denotes +
T7975 1414-1415 SO_EXT:normal_or_wild_type_or_present denotes +
T7974 1410-1414 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T7973 1384-1397 CHEBI:17387 denotes acylcarnitine
T7972 1378-1383 UBERON:0001977 denotes Serum
T7971 1351-1364 CHEBI:17387 denotes Acylcarnitine
T3291 1326-1339 CHEBI:17387 denotes acylcarnitine
T3290 1307-1312 NCBITaxon:10088 denotes mouse
T3262 767-771 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T3261 761-762 SO_EXT:normal_or_wild_type_or_present denotes +
T3260 759-760 SO_EXT:normal_or_wild_type_or_present denotes +
T3259 755-759 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T3258 722-731 CHEBI:17126 denotes carnitine
T3257 716-721 UBERON:0001977 denotes serum
T3256 666-670 NCBITaxon:10088 denotes mice
T3255 664-665 SO_EXT:sequence_nullness_or_absence denotes −
T3254 662-663 SO_EXT:sequence_nullness_or_absence denotes −
T3253 658-662 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T3252 652-653 SO_EXT:normal_or_wild_type_or_present denotes +
T3251 650-651 SO_EXT:normal_or_wild_type_or_present denotes +
T3250 646-650 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T3249 604-613 SO_EXT:genotype_or_entity_with_genotype denotes genotypes
T3248 599-603 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T3247 527-538 CHEBI:15344 denotes acetoacetic
T3246 506-522 CHEBI:20067 denotes β-hydroxybutyric
T3245 471-475 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T3244 440-451 CHEBI:30832 denotes Adipic acid
T3243 415-428 CHEBI:64709 denotes organic acids
T3242 347-348 SO_EXT:normal_or_wild_type_or_present denotes +
T3241 345-346 SO_EXT:normal_or_wild_type_or_present denotes +
T3240 341-345 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T3239 310-325 CHEBI:64390 denotes hexanoylglycine
T3238 292-305 CHEBI:41865 denotes sebacic acids
T3237 300-305 CHEBI:9300 denotes acids
T3236 279-286 _FRAGMENT denotes suberic
T3235 300-305 CHEBI:30832 denotes acids
T3234 271-277 _FRAGMENT denotes adipic
T3233 215-219 NCBITaxon:10088 denotes mice
T3232 213-214 SO_EXT:sequence_nullness_or_absence denotes −
T3231 211-212 SO_EXT:sequence_nullness_or_absence denotes −
T3230 207-211 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T3229 155-160 NCBITaxon:9606 denotes human
T3228 140-144 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T3227 108-120 CHEBI:64709 denotes organic acid
T3226 90-94 NCBITaxon:10088 denotes mice
T3225 88-89 SO_EXT:sequence_nullness_or_absence denotes −
T3224 86-87 SO_EXT:sequence_nullness_or_absence denotes −
T3223 82-86 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T3222 46-58 CHEBI:64709 denotes organic acid
T3221 40-45 UBERON:0001088 denotes Urine
T3220 17-30 CHEBI:17387 denotes Acylcarnitine
T3219 0-12 CHEBI:64709 denotes Organic Acid
T3289 1284-1290 NCBITaxon:9606 denotes humans
T3288 1267-1280 CHEBI:17387 denotes acylcarnitine
T3287 1224-1228 NCBITaxon:10088 denotes mice
T3286 1217-1223 SO_EXT:sequence_altered_entity_or_alteration_process denotes mutant
T3285 1190-1204 CHEBI:17387 denotes acylcarnitines
T3284 1125-1130 NCBITaxon:9606 denotes Human
T3283 1088-1092 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T3282 1082-1087 NCBITaxon:9606 denotes human
T3281 1049-1053 NCBITaxon:10088 denotes mice
T3280 1047-1048 SO_EXT:sequence_nullness_or_absence denotes −
T3268 791-792 SO_EXT:sequence_nullness_or_absence denotes −
T3267 789-790 SO_EXT:sequence_nullness_or_absence denotes −
T3266 785-789 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T3265 775-779 NCBITaxon:10088 denotes mice
T3264 773-774 SO_EXT:sequence_nullness_or_absence denotes −
T3263 771-772 SO_EXT:sequence_nullness_or_absence denotes −
T3279 1045-1046 SO_EXT:sequence_nullness_or_absence denotes −
T3278 1041-1045 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T3277 1011-1024 CHEBI:17387 denotes acylcarnitine
T3276 979-984 UBERON:0001977 denotes serum
T3275 951-964 CHEBI:17387 denotes acylcarnitine
T3274 909-922 CHEBI:17387 denotes acylcarnitine
T3273 904-908 UBERON:0001970 denotes Bile
T3272 869-882 CHEBI:17387 denotes acylcarnitine
T3271 836-853 CHEBI:86063 denotes decenoylcarnitine
T3270 830-835 UBERON:0001977 denotes serum
T3269 793-797 NCBITaxon:10088 denotes mice
R2068 T3235 T3234 _lexicallyChainedTo acids,adipic
R2069 T3237 T3236 _lexicallyChainedTo acids,suberic